INHALE THERAPEUTICS SYSTEMS

Company

NEKTAR THERAPEUTICS

Filed

February 7, 2002

Accession Number

0000921739-02-000014

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →